Sathguru led a study to assess local manufacturing capacity, pipeline strength and specifications of products in India for certain vaccines that were under consideration by the Government for near term adoption in the national immunization program.
Our client, the Immunization Technical Support Unit, is a collaborative effort of the Ministry of Health and Family Welfare (MoHFW), Government of India, the Public Health Foundation of India (PHFI) and other partners with funding from the Bill and Melinda Gates Foundation to provide techno-managerial support for scaling up India’s Universal Immunization Program (UIP) and support implementation of India’s strategic goals for immunization. To support decision making on adoption of additional vaccines in the UIP, ITSU was keen to understand capacity in India in specific identified vaccines.
Sathguru interacted with several doctors, clinical staff, mothers and families across segments and income classes in the chosen location. Through this extensive primary research effort, Sathguru analyzed high-level findings on product need, acceptability across clinical community and end user groups, key barriers to adoption, social and risk considerations, risk mitigation possibilities, operational considerations and commercial implications.Sathguru analyzed all regulatory implications of product related and health related regulations currently applicable in India.
The approach included analysis of information from a combination of sources – secondary research, primary research with Indian and multinational companies and information gathered from our prior interactionwith various stakeholders.
A report illustrating a comprehensive picture of current and emerging capacity in the identified vaccines with critical details on product specifications and qualitative insights required for use in policy making and implementation.